Boothbay Fund Management’s Achieve Life Sciences QUIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$443K Buy
+54,807
New +$392K 0.01% 1413
2021
Q2
– Sell
-33,389
Closed -$387K – 1815
2021
Q1
$387K Hold
33,389
– – 0.01% 1080
2020
Q4
$270K Hold
33,389
– – 0.01% 989
2020
Q3
$279K Buy
+33,389
New +$306K 0.02% 827
2016
Q4
– Sell
-28
Closed -$31K – 733
2016
Q3
$31K Buy
+28
New +$44.6K 0.01% 692

Other funds holding QUIT

Boothbay Fund Management's QUIT Position: Q3 2026 in Review

Boothbay Fund Management opened a new position in Achieve Life Sciences (QUIT) in Q3 2026: 54,807 shares worth $443K. The stake represents 0.01% of the portfolio and ranks #1413 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in QUIT as recently as Q1 2021.

Boothbay Fund Management first reported a position in QUIT in Q3 2016 and has held it in 5 quarters since. 132 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • Boothbay Fund Management held 54,807 shares of Achieve Life Sciences worth $443K as of Q3 2026.
  • Achieve Life Sciences was a new Boothbay Fund Management position in Q3 2026.
  • Achieve Life Sciences made up 0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1413 holding.
  • Boothbay Fund Management first reported a position in Achieve Life Sciences in Q3 2016 and has held it in 5 quarters since.
  • 132 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.